UK records another 36,100 coronavirus cases

Source: Xinhua| 2021-09-21 00:18:57|Editor: huaxia

LONDON, Sept. 20 (Xinhua) -- Another 36,100 people in Britain have tested positive for COVID-19, bringing the total number of coronavirus cases in the country to 7,465,448, according to official figures released Monday.

The country also recorded another 49 coronavirus-related deaths. The total number of coronavirus-related deaths in Britain now stands at 135,252. These figures only include the deaths of people who died within 28 days of their first positive test.

The latest data came as a trial of what has been described as the world's first multi-variant vaccine booster against COVID-19 kicked off in the British city of Manchester on Monday.

A married couple, both in their 60s, became the first participants in the trial, a collaboration between the University of Manchester and a National Health Service (NHS) foundation trust in the city.

Launched by U.S. pharmaceutical company Gritstone, the drug, called GRT-R910, is claimed to boost the immune response of first-generation COVID-19 vaccines to a wide array of variants of Sars-Cov-2, which cause COVID-19.

The phase one trial of the vaccine is taking place at the National Institute for Health Research Manchester Clinical Research Facility at Manchester Royal Infirmary.

A spokesman for the University of Manchester said data evaluating the vaccine is expected in the first quarter of 2022, with results from the pre-clinical studies published later in the year.

Meanwhile, the vaccine programme has been stepped up with booster invites being sent out to vulnerable Britons while 12 to 15-year-olds also starting to receive their first jabs.

Those aged 12 to 15 are being offered vaccines at some schools in England from Monday and the rollout is also beginning in Scotland and Wales this week.

More than 89 percent of people aged 16 and over in Britain have had their first dose of vaccine and more than 81 percent have received both doses, the latest figures showed.

To bring life back to normal, countries such as Britain, China, Germany, Russia and the United States have been racing against time to roll out coronavirus vaccines. Enditem